Association of Gene Dosage With Meniere Disease and Related Audiovestibular Phenotypes in X-Linked Hypophosphatemia
JAMA Otolaryngology–Head & Neck Surgery 10.1001/jamaoto.2026.0021April 16, 2026 at 11:00 AM EDT
In X-linked hypophosphatemia (XLH), caused by gene mutations, do some patients develop Meniere disease with endolymphatic sac hypoplasia (MD-hp), and what factors are associated with increased susceptibility?In this cross-sectional study of 33 patients with XLH, 6 hemizygous males with loss-of-function variants developed MD-hp at a prevalence far exceeding population estimates. In contrast, males with mosaic or hypomorphic variants and heterozygous females showed milder audiovestibular phenotypes..These results suggest a gene-dosage threshold model for MD-hp development in XLH, highlighting the need for early auditory and vestibular screening in affected individuals and paving the way for targeted interventions.
Link to the article in your story
We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)
Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
Need more information? Contact us.